ITMI932189A0 - Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta - Google Patents

Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Info

Publication number
ITMI932189A0
ITMI932189A0 ITMI932189A ITMI932189A ITMI932189A0 IT MI932189 A0 ITMI932189 A0 IT MI932189A0 IT MI932189 A ITMI932189 A IT MI932189A IT MI932189 A ITMI932189 A IT MI932189A IT MI932189 A0 ITMI932189 A0 IT MI932189A0
Authority
IT
Italy
Prior art keywords
acetylcarnosine
cataract
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
ITMI932189A
Other languages
English (en)
Inventor
Mark Babizhayev
Costa Edoardo Bozzo
Original Assignee
Bruschettini Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruschettini Srl filed Critical Bruschettini Srl
Priority to ITMI932189A priority Critical patent/IT1270905B/it
Publication of ITMI932189A0 publication Critical patent/ITMI932189A0/it
Priority to PCT/EP1994/003340 priority patent/WO1995010294A1/en
Priority to AU78127/94A priority patent/AU7812794A/en
Publication of ITMI932189A1 publication Critical patent/ITMI932189A1/it
Application granted granted Critical
Publication of IT1270905B publication Critical patent/IT1270905B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI932189A 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta IT1270905B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
PCT/EP1994/003340 WO1995010294A1 (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU78127/94A AU7812794A (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Publications (3)

Publication Number Publication Date
ITMI932189A0 true ITMI932189A0 (it) 1993-10-15
ITMI932189A1 ITMI932189A1 (it) 1995-04-15
IT1270905B IT1270905B (it) 1997-05-13

Family

ID=11367036

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Country Status (3)

Country Link
AU (1) AU7812794A (it)
IT (1) IT1270905B (it)
WO (1) WO1995010294A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
AUPR038200A0 (en) * 2000-09-26 2000-10-19 Beta Peptide Foundation Pty Ltd, The Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
JPWO2004064866A1 (ja) * 2003-01-20 2006-05-18 イノヴェイティブ ヴィジョン プロダクツ インコーポレーテッド カルノシナーゼ阻害剤とl−カルノシン類との併用および組成物
WO2005041870A2 (en) 2003-10-24 2005-05-12 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
US7776364B2 (en) 2006-03-24 2010-08-17 Advanced Scientific, Llc Non-surgical method for treating cataracts in mammals including man
CN106573957B (zh) 2014-07-31 2021-10-26 塞巴斯蒂安诺·舒托 由透明质酸和肌肽得到的衍生物
ES2632808T3 (es) 2014-09-04 2017-09-15 Nicox Science Ireland Compuestos de carnosina donadores de óxido nítrico
IT202000014017A1 (it) 2020-06-11 2021-12-11 Fidia Farm Spa Nuovi derivati ottenuti da acido ialuronico e carnosina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640613A (en) * 1979-09-13 1981-04-16 Nippon Chemiphar Co Ltd Novel type remedy for peptic ulcer
WO1990006102A1 (en) * 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
JPH07500580A (ja) * 1991-09-09 1995-01-19 ペプテック リミテッド 糖尿病の合併症及び病因の処理方法

Also Published As

Publication number Publication date
WO1995010294A1 (en) 1995-04-20
ITMI932189A1 (it) 1995-04-15
IT1270905B (it) 1997-05-13
AU7812794A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
IT1302559B1 (it) Busto ortopedico modulare regolabile per il trattamento dellascoliosi
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
IT9021645A0 (it) Procedimento per il trattamento di torbide di raffineria
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
ITMI950958A0 (it) Composizioni farmaceutiche per il trattamento della alcol-dipendenza
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IT232136Y1 (it) Macchina per il trattamento della massicciata di pietrisco
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
ITMI910381A1 (it) Medicamento per il trattamento della dermatite
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL105285A0 (en) Compositions for the treatment of diabetes
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IT1277117B1 (it) Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
FI932650A7 (fi) B-solujen maligniteettien hoitoon tarkoitetut farmaseuttiset seokset

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029